Pharmacological Therapies for COVID-19

( Last Updated : April 27, 2022)
Project Line:
Health Technology Review
Project Sub Line:
Technology Review


This report identifies and summarizes published guidance from Canadian jurisdictions that provide recommendations regarding which pharmacological therapies should (or should not) be used to treat COVID-19 across different severities of illness (i.e., critically ill, moderate to severely ill, mildly ill). In total, 40 publications from several Canadian jurisdictions were included and summarized.